<SEC-DOCUMENT>0001437749-12-012951.txt : 20121217
<SEC-HEADER>0001437749-12-012951.hdr.sgml : 20121217
<ACCEPTANCE-DATETIME>20121217171441
ACCESSION NUMBER:		0001437749-12-012951
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20121210
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20121217
DATE AS OF CHANGE:		20121217

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO KEY INTERNATIONAL INC
		CENTRAL INDEX KEY:			0001019034
		STANDARD INDUSTRIAL CLASSIFICATION:	COMPUTER COMMUNICATIONS EQUIPMENT [3576]
		IRS NUMBER:				411761861
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13463
		FILM NUMBER:		121269325

	BUSINESS ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719
		BUSINESS PHONE:		6516870414

	MAIL ADDRESS:	
		STREET 1:		3349 HIGHWAY 138
		STREET 2:		BUIDING D, SUITE B
		CITY:			WALL
		STATE:			NJ
		ZIP:			07719

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SAC TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19961115
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>biokey_8k-121012.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<html>
<head>
    <title>biokey_8k-121012.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="TEXT-ALIGN: center; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">UNITED STATES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt">Washington, D.C. 20549</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">FORM 8-K</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">CURRENT REPORT</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date of Report (Date of earliest event reported): December 10, 2012</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 18pt; FONT-WEIGHT: bold">BIO-key International, Inc.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Exact name of registrant as specified in its charter)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Delaware</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(State or other jurisdiction of </font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">incorporation)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">1-13463</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Commission File Number)</font></div>
</td>
<td valign="top" width="27%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">41-1741861</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(I.R.S. Employer Identification No.)</font></div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">3349 Highway 138, Building D, Suite B</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Wall, NJ 07719</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Address of principal executive offices)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">(732)&#160;359-1100</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(Registrant&#8217;s telephone number, including area code)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</td>
</tr><tr>
<td align="left" colspan="3" valign="top" width="80%">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<font style="FONT-STYLE: italic; DISPLAY: inline">see</font> General Instruction A.2 below):</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font>Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: -18pt; DISPLAY: block; MARGIN-LEFT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline;" face="Wingdings">o</font> Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</font></div>
</td>
</tr></table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 8.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Events.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">On December 10, 2012, BIO-key International, Inc. (the &#8220;Company&#8221;) issued a press release announcing an agreement with Blue Spike to resolve the Litigation, which resulted in a dismissal of all claims asserted in the Litigation (both against and by the Company) with prejudice, which is included as an exhibit to a Current Report on Form 8-K.&#160;A copy of the press release issued by the Company on December 10, 2012 is attached as Exhibit&#160;99.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; The information, including the exhibit attached hereto, in this Current Report on Form 8-K shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Item 9.01.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial Statements, Pro Forma Financial Information and Exhibit.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;&#160;Exhibits</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">99.1&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Press Release, dated December 10, 2012, issued by <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">the Company.</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">2</font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">SIGNATURES</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div>
<table border="0" cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-WEIGHT: bold"> </font>
<div style="TEXT-ALIGN: left; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">BIO-KEY INTERNATIONAL, INC.</font></font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Date: December 17, 2012</font></font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td align="left" valign="top" width="50%" style="BORDER-BOTTOM: #ffffff solid">&#160;</td>
<td valign="top" width="3%" style="BORDER-BOTTOM: #ffffff solid">
<div style="TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">By: </font></div>
</td>
<td align="left" nowrap valign="top" width="35%" style="BORDER-BOTTOM: black 2px solid; TEXT-INDENT: 9pt; PADDING-LEFT: 0pt; MARGIN-LEFT: 9pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline">/s/ Cecilia C. Welch</font></font></font></td>
<td valign="top" width="12%" style="BORDER-BOTTOM: #ffffff solid"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td align="left" nowrap valign="bottom" width="35%">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Cecilia C. Welch</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%">
<div align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Chief Financial Officer</font></div>
</td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr><tr>
<td valign="top" width="50%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="3%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="35%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font></td>
</tr></table>
</div>

<br>
</div>

<div id="PGBRK" style="TEXT-INDENT: 0pt; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="TEXT-ALIGN: center; WIDTH: 100%"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>

<div style="TEXT-ALIGN: center; WIDTH: 100%">
<hr style="COLOR: black" noshade size="2">
</div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 8pt">&#160; </font></div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div align="center"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">EXHIBIT INDEX</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div align="center">
<table border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Exhibit No.</font></font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; &#160;<font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Description</font></font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div>
<div style="TEXT-ALIGN: left; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">99.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Press Release, dated <font style="DISPLAY: inline; FONT-FAMILY: Times New Roman">December 10, 2012, issued by </font>the Company.</font></div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#160;</font><br>
&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
<head>
    <title>ex99-1.htm</title>
    <!--Licensed to: rdg filings-->
    <!--Document Created using EDGARizerAgent 5.4.1.0-->
    <!--Copyright 1995 - 2009 Thomson Reuters. All rights reserved.-->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">
<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">
<div style="TEXT-ALIGN: right; LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">Exhibit 99.1</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center">
<div>&#160;</div>

<div align="center">
<table bgcolor="white" cellpadding="0" cellspacing="0" width="100%" style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;<img src="biokeylogo.jpg" alt=""></font></td>
<td width="50%"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160; </font>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 108pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold">NEWS RELEASE</font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt">&#160;</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold"><font size="2"><font style="FONT-WEIGHT: normal"><font style="FONT-STYLE: normal">Contacts:<font id="TAB1" style="FONT-STYLE: normal; MARGIN-LEFT: 18pt; FONT-WEIGHT: normal"></font><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-WEIGHT: normal; TEXT-DECORATION: underline">BIO-key International, Inc.</font></font></font></font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold"><font size="2"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">&#160;&#160;&#160; Scott Mahnken</font></font></font></font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 72pt; MARGIN-RIGHT: 0pt" align="center"><font style="FONT-FAMILY: times new roman; FONT-SIZE: 10pt"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 24pt; FONT-WEIGHT: bold"><font style="FONT-STYLE: normal; DISPLAY: inline; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-WEIGHT: normal">732-359-1113</font></font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>
</div>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">BIO-key&#174; International, Inc.</font></div>

<div align="center"><font style="FONT-STYLE: italic; DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 12pt; FONT-WEIGHT: bold">Settles Patent Suit with Blue Spike LLC</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Wall, NJ, December 10, 2012</font> &#8211; BIO-key International, Inc. (OTCBB: BKYI.OB), a global leader in fingerprint biometric identification solutions and advanced mobile identification technology, today reported that the company has resolved litigation filed against it by Blue Spike, LLC.&#160;&#160;Blue Spike had filed suit against the Company in the United States District Court for the Eastern District of Texas alleging that the Company infringed one or more claims of U.S. Patents Nos. 7,346,472, 7,660,700, 7,949,494, and 8,214,175.&#160;&#160;The Company reached an agreement to resolve the Litigation, which resulted in a dismissal of all claims asserted in the Litigation (both against and by the Company) with prejudice.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">&#8220;We are pleased to have quickly settled the patent suit with Blue Spike and we continue to make very good progress in our previously announced objective to bring the company to profitability for FY 2012&#8221;, stated Mike DePasquale BIO-key CEO.&#160;&#160;The company is planning to hold a conference call in the coming weeks to update our investors on a number of strategic initiatives that are underway.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">About BIO-key</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">BIO-key International, Inc., headquartered in Wall, New Jersey, develops and delivers advanced identification solutions to commercial and government enterprises, integrators, and custom application developers.&#160;BIO-key&#8217;s award winning, high performance, scalable, cost-effective and easy-to-deploy biometric finger identification technology accurately identifies and authenticates users of wireless and enterprise applications. Our solutions are used in local embedded OEM products as well as some of the world&#8217;s largest identification deployments to improve security, guarantee identity, and help reduce identity theft.&#160;&#160;BIO-key&#8217;s technology is offered directly or by market leading partners around the world. (<font style="DISPLAY: inline; FONT-WEIGHT: bold">http://www.bio-key.com</font>)</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block"><br>
</div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold">BIO-key Safe Harbor Statement</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block; MARGIN-LEFT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt">Certain statements contained in this press release may be construed as &#8220;forward-looking statements&#8221; as defined in the Private Securities Litigation Reform Act of 1995 (the &#8220;Act&#8221;).&#160; The words &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;intends,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;believes&#8221; and similar expressions are intended to identify forward-looking statements.&#160; Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the &#8220;safe-harbor&#8221; provisions of the Act.&#160; These statements are subject to certain risks and uncertainties that may cause actual results to differ materially from those projected on the basis of these statements.&#160; These risks and uncertainties include, without limitation, our history of losses and limited revenue, our ability to develop new products and evolve existing ones, the impact on our business of the recent financial crisis in the global capital markets and negative global economic trends, our ability to attract and retain key personnel.&#160; For a more complete description of these and other risk factors that may affect the future performance of BIO-key International, Inc., see &#8220;Risk Factors&#8221; in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2011 and its other filings with the Securities and Exchange Commission.&#160; Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made.&#160; The Company also undertakes no obligation to disclose any revision to these forward-looking statements to reflect events or circumstances after the date made or to reflect the occurrence of unanticipated events.</font></div>

<div style="LINE-HEIGHT: 1.25; TEXT-INDENT: 0pt; DISPLAY: block">&#160;</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>biokeylogo.jpg
<TEXT>
begin 644 biokeylogo.jpg
M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`!
M````/@```!L!!0`!````1@```"@!`P`!`````@`!`3$!`@`0````3@``````
M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,`#@H+#0L)
M#@T,#1`/#A$6)!<6%!06+"`A&B0T+C<V,RXR,CI!4T8Z/4X^,C)(8DE.5EA=
M7ETX169M95IL4UM=6?_;`$,!#Q`0%A,6*A<7*ED[,CM965E965E965E965E9
M65E965E965E965E965E965E965E965E965E965E965E965E96?_``!$(`)<`
MR@,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_
MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C
M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-C<X.3I#1$5&1TA)2E-45597
M6%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ
MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X
M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($
M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B
M<M$*%B0TX27Q%Q@9&B8G*"DJ-38W.#DZ0T1%1D=(24I35%565UA96F-D969G
M:&EJ<W1U=G=X>7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X
MN;K"P\3%QL?(R<K2T]35UM?8V=KBX^3EYN?HZ>KR\_3U]O?X^?K_V@`,`P$`
M`A$#$0`_`/1J***0@HHHH`**R]4UZQTL%9I=TO:).6_^M^-<AJ/C"_N25M@M
MK'_L\M^=1*I&)T4L-4J:I:'?3W$-LF^>:.)?5V`K(N?%>DP9`G:8CM&I/Z]*
M\XFFEG<O-(\CG^)V)-)'&\KA(D9V/15&36+KOHCNC@(K6;.VE\<VX_U-G*W^
M\P7_`!JL?'4F?EL$Q[R'_"LBV\,:M<X(MO*4]Y6"_IUK3B\#W3#][=PI_NJ6
M_P`*7-58W3PD-R0>.I>]BG_?P_X5/%XZC/\`K;%U_P!V0'^@I%\"I_%?L?I%
M_P#7H?P*F/DOV'UCS_6J_>F;>#?],T;?QAI4Q`=I83_MI_AFM>UO[2\&;:XB
ME]E8$_E7&R^![I0?*NX7_P!Y2O\`C6;/X9U>T.];<OMZ-"V3_C3YYK=$NAAY
M_!.QZ;17F]GXEU739/+N"TJCK'.#N'X]:Z[2?$MCJ6(]WD3G_EG(>OT/>KC4
MC(YZN%J4]=T;5%%%:',%%%%`!1110`4444`%%%%`!114%W=0V=L\]PX2-!DD
MT`E?1#YYH[>%I9G5(U&2S'`%</K?BZ6X+0:<3%%T,O\`$WT]/YUEZ[KD^KSD
M',=LI^2//ZGWK(KEJ56](GKX?!J/O5-Q6)8DL22>23WJS8V%SJ$WE6L+2-WQ
MT'U/:MG0/#$NI;;BZW0VO;^\_P!/0>]=[:6EO90"&VB6.,=@/Y^M*%)RU9=?
M&1I^[#5G,Z9X+AC`?4)3*W_/-#A?SZG]*Z:VL[>T39;01Q+Z*N*GHKIC!1V/
M*J5IU/B844451D%%%07-Y;VB;[F>.)?5V`S0-)O1$]%8$_B_28B0LDDI_P!A
M#_7%5O\`A-]/S_J+G'KM7_&I]I'N;+#U7]EG0W5G;7D>RY@CE7_:7.*Y?5/!
M<;9DTV4QMU\N0Y'X'J*TK?Q;I,Q`,SQ$_P#/1"/U%;$%Q#<QAX)4E0]T8$4F
MH3'&5:AW1QFFZ_?:-<"RUB.0QC@,W+*/7/\`$*[2&:.XA66%U>-QE64Y!J&_
MT^VU&W,-U$'7L>ZGU![5RB?;/"-X`Y:?2Y6Z_P!T_P!#_.EK#?8MJ%?6*M+M
MW.UHID,J3Q)+$P='&58="*?6AR!1110`4444`%%%%`"$A023@#DFO-O$VMMJ
MEX8XF(M(CA!_>/\`>_PKH_&FJ&UL5LXFQ+<#YL=D[_GT_.O/ZYJT_LH]7`T-
M/:2^05U/A7P[]M*WMXO^CJ?D0_\`+0^I]OYUE^'M*.K:BL39$"?-*1Z>GXUZ
MA&BQ1JB*%11@`=`*5*G?5EXS$<BY([B@```#`'84M%%=1XX4444`%-=E1"SL
M%51DD]!3JYGQK]N>QBBM8W>%B?-V#)]AQVI2=E<NG#GDHWL9^M^,'+M!IF%4
M<&8CD_0?UJCI_AS4=787-Y(\4;<[Y<EV^@K3\*^&]@%[J$7S]8XG'3W(KL:Q
MC!SUF=M2O&C[E%?,PK/PGI=L!OB:X;UE.?T'%:2:981C"65NH]HE_P`*MT5L
MHI;(XY59RW91ET?39AB2QMS[B,`_I69)X7B@D\[2KF:RF'HVY3]0:Z&BAQ3"
M-6<=F8UEJ=Q#<+9:M&L4[<1RK_JY?IZ'VK4N((KJ!X9D#QN,,I[TV\M(;VW:
M"=-R-^8/J/0U7TR651)9W+;YH,8<_P#+1#T;Z\$'W%"TT8.S]Z.C,C2C)H6J
M?V5.Q:TG):VD;L>Z_P"?ZUTU9VMZ>-1T]HU^6=/GB?NKCI4FD7GV_389V&)"
M-LB^C#@C\Z4=-"JCYUS]>I=HHHJC$****`"BBB@#RG7KXZAJ]Q-G*!MB?[HX
M'^/XUG5N:IX:U"SN7$,#SPDY1XQGCW'K4VB^%[N[N5>\A:"V4Y;>,,WL!7"X
MR<MCZ"-:E"FFGH33WEYX5\*07-I:>;/=-ODE925B&/ESCV_K7)Q:]XDUZ_CM
M8;^<S3'"I&WECU[8KU'Q:`OA/4@!@"`X%>7_``^_Y'&R^DG_`*`U=T596/"G
M-SDY/J:-_HWB_1[9KUKZ>1(QN<Q7+,5'J0:U_!?C:>]O(].U4J\DG$4P&"3Z
M-_C7::S<P6FD7<URRK$(FSN[\=/QKQ7PM;2W7B73TA!+"=7..P!R3^0IDG6>
M-;OQ)HU\;@:F5M+B1A"L9QM`[$8J/P;>>)=;OQ*NIDVUNZF82G.X'L!CT!K0
M^+'_`!X:=_UU?^0J/X3']QJG^]'_`":@#J?$WB2U\/6@>4>9<29\J$'!;W/H
M*\]C\1>*O$ETT.GNZCJ4MP$"#W8_XUB^*=4?5]?NK@L3&'*1#T0'`_Q_&O7O
M"NDQZ/H5M"J`2NHDE;N6(Y_+I0!Y_<Z-XUL$-S]HNY,<MY=R7(_#/-6?#WQ"
MNH9TM]:Q+"3CS@N'3Z@=1^M>H5Y)\2M)CL=9BNX$")=J2P`XWCJ?QR/UH`]9
MCD26-9(V#(P!5@<@BG5Q/PRU1KO1YK*5BSVC#:3_`'&S@?@0:[:@14U2>YMM
M.GFL[?[3<(N4BSC<:\G/BS7;G7K=;BY>#;.JM`@V*/FP01W_`!KV.O#=0_Y'
MBX_["!_]&4`>Y57EB/VR"9!R`R-_ND9_F!^=3-(BG#.H/N:%=6^ZP;Z&D-.P
MZLNP3[+JU];CB.7;<(/<\-^HS^-:3ND:%W944=2QP!6<MW:3ZK`]O=V\C"-T
M94E4GDJ1QGV-)CB]T:=%-9U7[S!?J:02(QP'4GT!IDCZ*:SJOWF4?4T*ZL"5
M8''7!H`=13(Y$E7=&ZN.F5.:?0`4444`8WB[_D5=3_ZX-7D_@R*>?Q%%%:R^
M3.\4HCD_NMY;8->L>+O^15U/_K@U>7_#P_\`%8V?^[)_Z`:8RQKGA3Q-';M<
M7DC7L<?)*S%RH]<'FI_A_KVGZ9=_9KJV1)9SM%WG)&>BGT'N/QKUD\CFOGW5
MD2+6;U(<>6D[A,>@8XH`]#^+'_'AIW_75_Y"JWPO)&G:T5^\`F/R:D^(K._A
MW0VESYC#+9]=@S4OPG`-OJH/0M'_`":@#SF`!KF,-T+C/YU]%#H,5X#KE@^E
MZU=VC`CRI"%]UZ@_EBO;M!U!-4T6TNT(/F1C=[,."/SS0!HUP'Q7`_LW3S_%
MYS`?3'_ZJ[^O+/BEJ*3ZE;6,;`_9D+/CLS8X_(#\Z!"_"IMNI:ADX3R`23T^
M]_\`KKTK[;:XS]IAP?\`IH*\[\$>'Y;WPMJKA_*:^7RHF/HO4_0DX_"JW_"L
MM4_Y_;/\V_PH&>GI=6\CA8YXG8]`K@FO$]0_Y'BX_P"P@?\`T976:%\/[_3=
M9M+R:\MS'"X<B/=DX[=*XS6T>7Q7?QQ<2/>.J\XY+G%`&YXU@@U;Q?\`9]),
MMQ=R$)*-V4#`8P/3`'-=IX<\,6OA:":]EN7DE\D^:QX10.3@?A7GGAS4Y/"_
MB1C>PXP3#.&&649Y(_SS7J/B>03^$=0EMG#J]L65E.05QU_*@#S*^U+4/&GB
M"*U5RD4CXBBS\J+ZGU..:O>+/!UOX?TR&\@O7>3>$97`!8^JXK&\)WEQ8:I)
M<6=O]HNE@?RH\9R>,G'?`R:Z6R\*:UXEN5OO$%Q)!$>B-]_'H%Z*/\XH`Q[.
MUNO%&C7D\TTTMYID2^62<B1.25/N,'FH_`=I:WGB6!+J62-D_>1;#C<R\X/X
M9KUW2]*L])M!;64*QQ]3W+'U)[UY!XALY?#/BUFMAL5)!/`>VTG./YB@#I_B
MCI]JL4&H-+(+IR(ECS\I49)..W_UZL>&O"[Z?H(O,RO<W2*TD/8)G(&.YZ$_
MB*R;Z[7QIXRT^"')LHD5F![#[S_T7\*]1RJ@#@`4`8FAV\T<Y9@^T*0[E64/
M]W:,-SQAOS_`;M(#GI2TA!1110!ROCZ+5Y]'$6EQF2)\BX5%RY7MCVZ].:\L
MTJ]N=`UB&\\@B6$G]W(",@C!'Y&O?:CDABE&)8T<>C*#3`\RO_B5=7-JT-G8
M+;RN-OF&3>5^@P.:S_"W@Z]U:]CN+Z%X+%3N8R`@R>P'OZUW7_"0Z1::,FK+
M9&.!YS!\L2A@<D9X[<5K-J]O_:-K9H&D:YA::-UP5*C_`/70,\Y^(6KR:C=K
MIR6,L2V4C#>P^_VX&.E,^'VKRZ5?O9M8S2B]D1=Z@_)C(SC'3G]*[7_A+5^V
M_9/[&U3[1L\SR_*7.W.,_>Z9JQ>>(TMM3DL(M.OKJ:-%=O(12`#T[T`4/&?A
M)=>C%S:E4OHUP-W`D'H??T-<'INJZYX-N'AD@=(V.6AF4[6/J#_45Z=>>(4L
MM-M[R>QO%:XE$*P;!YFXYQQGVI+'7;;4;XZ?<65S:W!3S%CNH@-Z^HY-`'#7
MGQ*U">`QVEG%;R,,;]Q<CZ#_`/75#0?"&IZ]>?:;X2P6SMNDFE&&D]<`]?KT
MKO[#7='ET^_OK:U"?82WFH(U#\=QCUYK3O-8M[+1?[4F#^3L5PH`W'=C`^O-
M`%NUMH;.UBMK=`D,2A54=@*FK*36XY]%AU*TMKFZ27&(HE!<=CD9[8JMI/B5
M-6E*PZ=?1QJ65I9$`12O4$@]:!&EJM\--TV>\,4DPA7=LC&2:\.N+B6;7)-1
M%M(`]P9]F#_>SC->Q+XFL3H,6K,LJPS,4CCVY=VR1@`=^*6P\0P75^EE<6EU
M8W,BEHTN$"^8!UP0>OM0!R?BC2?^$FT2'Q!8VLD-R%/F0L/F=0<9]R,?B*S_
M``;XCGM(AH]]9SW-K.VQ-H.4#<$8[CG^==[9^(K*[GU*",2++IY;S$8#+`9R
M5YY'%6(]7MFT(:N0R6YA\[#`;L8Z?6@9Y7JV@ZIX3UA;RU5W@C??%.JY`'HW
MIZ>];!^)=Y+`(H-,3[4PP&WEAGV7&?UKO-'U>VUG31>VX<1DLK(X&Y2.H-&C
M7=IJ=A'?VD'EI+G&Y`&X)';Z4`8/@BSUL276HZS/,/M(&R&0\CGKC^'TQ5;X
MGZ;'/HT5^"JRVSA>?XE;C'YX/YUW%>3^.M;?7=9ATJP.^"*38,=))#QGZ#I^
M=`B_\/K=-+T2_P!=N%R6'EQCU`Z_FV!^%9FH:A<ZC<--<RLQ)X7/"^P%;WB:
M2/3=+L=#MR,0H&D([_\`ZSDURU<E:5W8]C`T4H\[6K-WPKJ-S;ZO;P+(QAF;
M8R$Y'UKTJO/_``18?:-2>[<?);CCW8__`%LUZ!6M&_+J<F.<?:V04445J<04
M444`>>0V,TGA'3K>6VD;.J@O&R'[F]LDCTQ5G2-.O=-\9V]G(CO96T,OV>8@
MD;&((4GU!R*[JBF!SIAD_P"%@B;RW\K^S=N_:=N?,Z9]:Q=8CC3QA>RW3:K#
M"T$81[$/\Q[@D"MW6M0O=(OXKHDRZ:_RR(%&4/KFMJWGBNH$F@</&XR&'>I4
MDW8MP:2ET9Q^LQ?;]#T:.S;4&07Z`RRJWG*/FRQR.WJ:FTBRFTWQ=*FH&YO6
MDB_T6\D);:O=#V!]_P#&NJN(VE@=$E:)B.'7&5_.L![W6M()%W;C4;<=)HAA
MP/<4.5APAS[/4Y.71[V#PY+?V4$GGR&>WN8=IS)&SG:V/4''X5N:I%J%^-!T
MVSA4^3$EU*9PPCRH`520/7/%:D/B_2I/]8TL+=PZ'C\LU,?%.C@9^UY^D;?X
M4N>/<IT:B^RS.\)I?:;J.H:7?0JJLWVF%H@QC&X_,H)]#CCZU/X0ADBTB^66
M-T8W<Q`92"03P:9<^-;",$6\4TS=N-H_7_"L23Q!K>JW`6Q5XQV2%<_F3_\`
M6J75BMC2.$J2U:LO,+2QO(O">@W2VLLC6%TTTL`7YRN]N0/6M.6Z/B'Q#I+V
M5M<);V+M+--+$4`R,!1GJ:T-&T_5U=9M3U"0XY$*D'\SC^5;]6G<PG%1=D[G
MG4VDWBQ:QJEE"XO(;Z<;"I_?0L`"/?U%6+F"^NO"N@Z-;0$2W"JTWFJP553G
M#$#C)Q^5=[15$'(:%%J.F>(+^VOH8Q'?I]H0VX8QJXX(R1P3UJ+PAK$5AHMI
MI]S;7J7`=E/^C/M&7..<>]=I10`UU#HR-T88-<B_AS0O#+?VJJ2M+%_JE>3(
M+'I@5T]]>P6%LT]RX1%_,GT'O7FFMZO-J]WYC_+$O$<>?NC_`!K*I4Y5YG5A
ML.ZLM=BE=7,EW<R7$S;I)&W$U'&C2R+'&I9V.%`[FFUV_@_03$%U&[3#D?N4
M/8?WJY8Q<V>O6JQHPN;^A::NEZ9'!P9#\TA'=CU_PK1HHKN2LK'@2DY-MA11
M102%%%%`!1110!'/!'<P/#,@>-QAE/>N,D%]X1O"T8:XTV1NA[?X'^==O3)H
MHYXFBE17C88*L,@U,HWVW-:57DT:NGT*NFZI:ZG`)+60-_>4\,OU%7:XC5/#
M-WITYO-&DD(7G8I^=?IZC_/-+IWC.2(^5J<!8C@R(,-^(J54MI(V>&YUS4G=
M?B=9<Z=97?-Q:PR'U9!G\ZHMX8T=CG[&H^CL/ZU:LM7L+\#[/<QLQ_@)PWY&
MKU5:+U,.:I#2[1F1>']*A.5L82?]H;OYUH1QI$H6-%11T"C`I]%4DEL2YREN
MPHHHH)"BD9E5268*!W)K'O\`Q-IED"//\YQ_#%\WZ]*3:6Y482F[15S9K(UC
MQ!9Z4I5F\VXQQ$IY_'TKDM4\77MX"EL/LL1_NG+G\>WX5SK$L2S$DGDD]ZPG
M6_E/0HX!O6I]Q=U35;K5;CS;E^!]U!]U?I5&K-C87.H3"*UA:1N^.@^I[5W6
MA>%8+`K/=[9[D<@?PI]/4^]91A*;N=M2M3H1M^!F>&?##2,EYJ"80<QPMW]S
M[>U=L.*6BNN,5%61XM6M*K+FD%%%%49!1110`4444`%%%%`!1110`5F:IH5C
MJ@)GBVR]I4X;_P"O^-:=%#2>C*C)Q=XL\^U#P;?6Y+6CK<IV'W6'X=*S1?:Q
MI;!&FNH,=%DSC\CQ7J=->-)%*R(KJ>S#(K%T5]EV.R.-E:U17/.8O%^K)]Z2
M*3_>C'],58'C;4>\-L?^`M_C763^'M*N"2]E&I/=,K_*J,G@W2F.5\]/]V3_
M`!!I<E1;,T5?#/>!@/XUU(CY8K9??:?\:J3>*=7F&/M(C'^P@%=-_P`(3IO_
M`#UNO^^U_P#B:4>"M,'62Z/_``,?X5/)5[EJMA5M'\#A+B\N;HYN+B67_?<F
MH>IQ7I,/A/2(SDP/(?\`;D/]*TK;3;*T_P"/>UAC/JJ#/YT>QD]V4\?3CI&)
MYM9:%J5\1Y-JX0_QN-H_6NFT[P5%&0^H3&4_\\X^%_/J?TKKJ*TC1BCDJ8VI
M/1:$-M;06L0BMXDB0=E&*FHHK4XV[[A1110`4444`%%%%`!1110`4444`%%%
H%`!1110`4444`%%%%`!1110`4444`%%%%`!1110`4444`%%%%`'_V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
